Page 63 - ITPS-7-1

INNOSC Theranostics and
Pharmacological Sciences Management and maintenance of oral health

https://doi.org/10.1186/s40729-021-00323-0 46. D’Agostino S, Valentini G, Dolci M, 2023, Potential
relationship between poor oral hygiene and MRONJ: An
34. Poxleitner P, Engelhardt M, Schmelzeisen R, et al., 2017, The
prevention of medication-related osteonecrosis of the jaw. observational retrospective study. Int J Environ Res Public
Dtsch Arztebl Int, 114: 63–69. Health, 20: 5402.
https://doi.org/10.3390/ijerph20075402
https://doi.org/10.3238/arztebl.2017.0063
47. Lorenzo-Pouso AI, Pérez-Sayáns M, Chamorro-
35. Rosella D, Papi P, Giardino R, et al., 2016, Medication-related
osteonecrosis of the jaw: Clinical and practical guidelines. Petronacci C, et al., 2020, Association between periodontitis
J Int Soc Prev Community Dent, 6: 97–104. and medication-related osteonecrosis of the jaw: A systematic
review and meta-analysis. J Oral Pathol Med, 49: 190–200.
https://doi.org.10.4103/2231-0762.178742
https://doi.org/10.1111/jop.12963
36. Casu C, Mosaico G, Natoli V, et al., 2021, Microbiota of the
tongue and systemic connections: The examination of the 48. Ruggiero S, Gralow J, Marx RE, et al., 2006, Practical
tongue as an integrated approach in oral medicine. Hygiene, guidelines for the prevention, diagnosis, and treatment of
1: 56–68. osteonecrosis of the jaw in patients with cancer. J Oncol
Pract, 2: 7–14.
https://doi.org/10.3390/hygiene1020006
https://doi.org/10.1200/JOP.2006.2.1.7
37. Ohnishi, Y, Ito K, Kitamura R, et al., 2017, Importance of
professional oral hygiene in preventing medication-related 49. Kunchur R, Goss AN, 2008, The oral health status of patients
osteonecrosis of the jaw. Int J Oral Med Sci, 15: 85–92. on oral bisphosphonates for osteoporosis. Aust Dent J,
53: 354–357, quiz 366.
38. Drudge-Coates L, Van den Wyngaert T, Schiødt M, et al.,
2020, Preventing, identifying, and managing medication- https://doi.org/10.1111/j.1834-7819.2008.00078.x
related osteonecrosis of the jaw: A practical guide for nurses 50. Migliorati CA, Brennan MT, Peterson DE, 2019, Medication-
and other allied healthcare professionals. Support Care related osteonecrosis of the jaws. J Natl Cancer Inst Monogr,
Cancer, 28: 4019–4029. 53: lgz009.
https://doi.org/10.1007/s00520-020-05440-x https://doi.org/10.1093/jncimonographs/lgz009
39. Pickett F, American Academy of Oral Medicine, 2006, 51. He L, Sun X, Liu Z, et al., 2020. Pathogenesis and
Bisphosphonate-associated osteonecrosis of the jaw: multidisciplinary management of medication-related
A literature review and clinical practice guidelines. Am Dent osteonecrosis of the jaw. Int J Oral Sci, 12: 30.
Hygienists Assoc, 80: 10.
https://doi.org/10.1038/s41368-020-00093-2
40. Rayman S, Almas K, Dincer E, 2009, Bisphosphonate‐related
jaw necrosis: A team approach management and prevention. 52. Bedogni A, Mauceri R, Fusco V, et al., 2023. Italian position
Int J Dent Hyg, 7: 90–95. paper (SIPMO-SICMF) on medication-related osteonecrosis
of the jaw (MRONJ). Qeios, preprint.
41. AlRowis R, Aldawood A, AlOtaibi M, et al., 2022, Medication-
related osteonecrosis of the jaw (MRONJ): A review of https://doi.org/10.32388/PBUJ6Z
pathophysiology, risk factors, preventive measures and 53. Ali IE, Sumita Y, 2022, Medication-related osteonecrosis
treatment strategies. Saudi Dent J, 34: 202–210. of the jaw: Prosthodontic considerations. Jpn Dent Sci Rev,
58: 9–12.
42. Mario M, Melle M, Bonda PL, 2010, Bisfosfonati e
osteonecrosi dei mascellari: Protocolli clinici per igienisti 54. Winter A, Schulz SM, Schmitter M, et al., 2022, Oral-health-
dentali. Prev Assist Dent, 36: 42–48. related quality of life in patients with medication-related
osteonecrosis of the jaw: A prospective clinical study. Int J
43. Yong CW, Robinson A, Hong C, 2022, Dental evaluation
prior to cancer therapy. Front Oral Health, 3: 876941. Environ Res Public Health, 19: 11709.
55. Ali IE, Murase M, Yonehara Y, et al., 2022, Time and cost of
https://doi.org.10.3389/froh.2022.876941
maxillofacial prosthetic treatment: The need for assessment.
44. National Cancer Institute. Available from: https://www. Jpn Dent Sci Rev, 58: 67–68.
oral and dental management prior to cancer therapy and
management following cancer therapy [Last accessed on https://doi.org/10.1016/j.jdsr.2022.02.001
2023 May 20]. 56. Kammerhofer G, Vegh D, Bányai D, et al., 2023,
Association between hyperglycemia and medication-related
45. Abed HH, Al-Sahafi EN, 2018, The role of dental care providers
in the management of patients prescribed bisphosphonates: osteonecrosis of the jaw (MRONJ). J Clin Med, 12: 2976.
Brief clinical guidance. Gen Dent, 66: 18–24. https://doi.org/10.3390/jcm12082976

Volume 7 Issue 1 (2024) 8 https://doi.org/10.36922/itps.1419